TMCnet News

European Transcatheter Mitral Valve Replacement Market Report 2017 - Research and Markets
[May 22, 2017]

European Transcatheter Mitral Valve Replacement Market Report 2017 - Research and Markets


Research and Markets has announced the addition of the "Transcatheter Mitral Valve Replacement" report to their offering.

This report presents a summary of the reimbursement situation for a transcatheter mitral valve replacement for mitral regurgitation.

Report includes essential information about reimbursement and national funding of the transcatheter mitral valve replacement for mitral regurgitation, including:

- Brief overview of reimbursement system for medical devices

- Procedure coding for technology

- Diagnosis coding

- Payment mechanism for technology

- Reimbursement tariffs for technology

- Restrictions in indications or scenarios for use of technology

- Policy considerations y payers and policy-makers about technology



Key Topics Covered:

1. Introduction and summary


2. Executive summary table

3. Contents

4. Methodology

5. Reimbursement analysis in Austria

6. Reimbursement analysis in Belgium

7. Reimbursement analysis in Denmark

8. Reimbursement analysis in England

9. Reimbursement analysis in France

10. Reimbursement analysis in Germany

11. Reimbursement analysis in Italy

12. Reimbursement analysis in the Netherlands

13. Reimbursement analysis in Norway

14. Reimbursement analysis in Sweden

15. Reimbursement analysis in Switzerland

Companies Mentioned

- Caisson Interventional (Caisson Transcatheter Mitral Valve System)

- Edwards Lifesciences (CardiAQ-Edwards Transcatheter Mitral Valve)

- HighLife (HighLife transcatheter mitral valve replacement device)

- Medtronic (TMV)

- MitrAssist

- NaviGate Cardiac Structures (NAVI System)

For more information about this report visit http://www.researchandmarkets.com/research/542ks7/transcatheter


[ Back To TMCnet.com's Homepage ]